Download Citation
Article Source:
Serum A-FABP Is Increased and Closely Associated with Elevated NT-proBNP Levels in Type 2 Diabetic Patients Treated with Rosiglitazone
Zhou M,
Bao Y,
Lu J,
Zhou J,
Jia W
(2011)
Serum A-FABP Is Increased and Closely Associated with Elevated NT-proBNP Levels in Type 2 Diabetic Patients Treated with Rosiglitazone.
PLOS ONE 6(10): e27032.
https://doi.org/10.1371/journal.pone.0027032